critical °Ë»ö°á°ú

100 °Ç (1/10 ÂÊ)
»ó¼¼Á¶°Ç    ÆÄÀÏÁ¾·ù 

ÀÀ±Þ½ÇER Æó·Å, COPD »ç·Ê¿¬±¸º¸°í¼­, Critical Pathway

ÀÀ±Þ½ÇER Æó·Å, COPD »ç·Ê¿¬±¸º¸°í¼­, Critical Pathway

ÀÀ±Þ½ÇER Æó·Å, COPD »ç·Ê¿¬±¸º¸°í¼­, Critical Pathway / ¥°. ¼­·Ð 1. »ç·Ê ¼±Á¤ÀÌÀ¯ 2. Åë°èÀû ÀÚ·á ¥±. ¹®Çå°íÂû - Áúȯ¸í, Á¤ÀÇ, ¿øÀÎ, Áõ»ó. Áø´Ü. Ä¡·á, °£È£ ¥². Critical Pathway 1. Medical Diagnosispneumonia 2. C.C 3. Present Illness(PI) 4. Past History 5. Assessments 6. Tests 7. Psychosocial Status 8. Nursing Diagnoses 9. Treatment 10. Medicat¡¦
·¹Æ÷Æ® > ÀǾຸ°Ç   18page   3,000 ¿ø
¿©¼º°£È£ÇÐ critical thinking

¿©¼º°£È£ÇÐ critical thinking

¿©¼º°£È£ÇÐ critical thinking / 1.°ú ¸ñ ¸í 2.ÇнÀÁÖÁ¦ 3. °£È£»ç´Â À̾ç°ú ¾î¶»°Ô À̾߱⸦ ½ÃÀÛÇÒ±î 4. ÇÇÀÓÀ» À§ÇØ °Ç°­°ü¸® Á¦°øÀÚ¸¦ ¹æ¹®ÇÏ´Â °Í¿¡ ´ëÇØ °£È£»ç´Â ¾î¶² ¸»À» ÇØÁÙ ¼ö ÀÖÀ»±î 5. °£È£»ç´Â Äܵ¼ »ç¿ë¿¡ ´ëÇØ ¹«¾ùÀ» ³íÀÇÇØ¾ß ÇÒ±î / 1.°ú ¸ñ ¸í ¿©¼º°£È£ÇÐÀº ¿©¼ºÀÇ »ý¸®Àû, ½É¸®Àû, »çȸÀû Ư¼ºÀ» ÀÌÇØÇÏ°í À̸¦ ¹ÙÅÁÀ¸·Î ÀûÀýÇÑ °£È£¸¦ Á¦°øÇÏ´Â Çй®ÀÌ´Ù. ¡¦
·¹Æ÷Æ® > ÀǾຸ°Ç   5page   3,000 ¿ø
¹°¸®È­ÇнÇÇè °è¸éÈ°¼ºÁ¦(surfactants)ÀÇ Critical Micelle Concentration(CMC) ÃøÁ¤ °á°úº¸°í¼­

¹°¸®È­ÇнÇÇè °è¸éÈ°¼ºÁ¦(surfactants)ÀÇ Critical Micelle Concentration(CMC) ÃøÁ¤ °á°úº¸°í¼­

¹°¸®È­ÇнÇÇè °è¸éÈ°¼ºÁ¦(surfactants)ÀÇ Critical Micelle Concentration(CMC) ÃøÁ¤ °á°úº¸°í¼­ / 1. Á¦¸ñ 2. ½ÇÇè °á°ú 1) ¼ö¿ë¾×°ú ¹Ì¼¿¿ë¾×¿¡¼­ ¾òÀº BZAÀÇ UV Èí¼ö ½ºÆåÆ®·³(Èí±¤µµ vs ÆÄÀå)À¸·ÎºÎÅÍ enol°ú keto forms¿¡ ±âÀÎÇÏ´Â µÎ Èí¼ö¶ìÀÇ ÃÖ´ëÈí¼öÆÄÀåÀ» ±¸ÇÑ´Ù. 2) °¢ ½Ã·á ¿ë¾×ÀÇ Èí¼ö ½ºÆåÆ®·³¿¡¼­ ¾Õ¿¡¼­ °áÁ¤ÇÑ µÎ ÃÖ´ëÈí¼öÆÄÀå, lambda_{max}(enol)°ú lambda_{max}¡¦
½ÇÇè°úÁ¦ > È­ÇÐ   6page   3,000 ¿ø
·Î·»Áî(Lorenz)ÀÇ °¢ÀÎÇö»ó¿¡¼­ °áÁ¤Àû½Ã±â(critical period)` °³³ä ÀÌÇØ

·Î·»Áî(Lorenz)ÀÇ °¢ÀÎÇö»ó¿¡¼­ °áÁ¤Àû½Ã±â(critical period)` °³³ä ÀÌÇØ

·Î·»Áî(Lorenz)ÀÇ °¢ÀÎÇö»ó¿¡¼­ °áÁ¤Àû½Ã±â(critical period)` °³³ä ÀÌÇØ / ¥°. ¼­·Ð ¥±. º»·Ð 1. °¢ÀÎ ¹× °áÁ¤Àû ½Ã±â 2. °áÁ¤Àû ½Ã±â ÀÌÈÄ Å¸ÀΰúÀÇ °ü°è Çü¼º 3. ±³»ç·Î¼­ÀÇ °áÁ¤Àû ½Ã±â ¥². °á·Ð ¥³. Âü°í¹®Çå / ¥°. ¼­·Ð ·Î·»ÁîÀÇ °¢ÀÎÇö»óÀº µ¿¹° ÇൿÇп¡¼­ Áß¿äÇÑ °³³äÀ¸·Î, ƯÈ÷ »õ³¢ µ¿¹°ÀÌ Æ¯Á¤ÇÑ °´Ã¼³ª °³Ã¼¿¡ ´ëÇØ °­ÇÑ ¾ÖÂøÀ» Çü¼ºÇÏ´Â °úÁ¤À» ¼³¸íÇÑ´Ù. ÀÌ ¡¦
·¹Æ÷Æ® > ÀÚ¿¬°úÇÐ   4page   3,000 ¿ø
°ÇÃà°ø»çÀÇ CFF(Critical Failure Factors)¿Í ÇعýÀÇ ÀÌÇØ

°ÇÃà°ø»çÀÇ CFF(Critical Failure Factors)¿Í ÇعýÀÇ ÀÌÇØ

°ÇÃà°ø»çÀÇ CFF(Critical Failure Factors)¿Í ÇعýÀÇ ÀÌÇØ / 1. ºñ°è °ø»ç 2. È븷ÀÌ °ø»ç 3. ±âÃÊ °ø»ç 4. ö±ÙÄÜÅ©¸®Æ® °ø»ç 5. Ä¿Æ°¿ù °ø»ç 6. ´Ü¿­ °ø»ç 7. ¹æ¼ö °ø»ç 8. ¼Ò°¨¹® / 1. ºñ°è °ø»ç ºñ°è °ø»ç´Â °ÇÃà°ø»ç¿¡¼­ Áß¿äÇÑ ºÎºÐÀ» Â÷ÁöÇÑ´Ù. ºñ°è´Â ÀÛ¾÷ÀÚ°¡ ³ôÀº °÷¿¡¼­ ¾ÈÀüÇÏ°Ô ÀÛ¾÷ÇÒ ¼ö ÀÖµµ·Ï ÇØÁÖ¸ç, Àüü °ø»çÀÇ ¾ÈÀü¼º°ú Ç°ÁúÀ» º¸ÀåÇÏ´Â ¿ªÇÒÀ» ÇÑ´Ù. ÇÏÁö¡¦
·¹Æ÷Æ® > °øÇбâ¼ú   7page   3,000 ¿ø
[´Ü±¹´ë] Critical Speed ½ÇÇè ·¹Æ÷Æ® A£«

[´Ü±¹´ë] Critical Speed ½ÇÇè ·¹Æ÷Æ® A£«

[´Ü±¹´ë] Critical Speed ½ÇÇè ·¹Æ÷Æ® A£« / 1. ½ÇÇè ¿ä¾à 1.1½ÇÇè ¸ñÀû 2. ½ÇÇè ÀÌ·Ð 2.1ºñ°¨¼è °­Á¦ Á¶È­ Áøµ¿ 2.2ȸÀüÃà°èÀÇ ºÒÆòÇü Áú·®¿¡ ÀÇÇÑ Áøµ¿ 3. ½ÇÇèÀåÄ¡ 3.1 ½ÇÇèÀåÄ¡ 3.2 ½ÇÇè °è»ê½Ä 4. ½ÇÇè ¹æ¹ý 5. ÁÖÀÇ »çÇ× 6. ½ÇÇè°á°ú 6.1 ½ÇÇè°á°ú 6.2 ÀÌ·Ð 7. ¿ë¾î Á¤¸® 8. °íÂû 9. Âü°í¹®Çå / 1. ½ÇÇè ¿ä¾à Critical Speed ½ÇÇèÀº ¹°Ã¼ÀÇ È¸Àü ¿îµ¿¿¡¡¦
·¹Æ÷Æ® > °øÇбâ¼ú   11page   3,000 ¿ø
ICH ÀÀ±Þ½Ç ÄÉÀ̽º ½ºÅ͵ð(Critical pathway)

ICH ÀÀ±Þ½Ç ÄÉÀ̽º ½ºÅ͵ð(Critical pathway)

ICH ÀÀ±Þ½Ç ÄÉÀ̽º ½ºÅ͵ð(Critical pathway) / ¨ç Daily outcomes ¨è Assessments ¨é Tests ¨ê Treatment ¨ë Medication Âü°í¹®Çå / ¨ç Daily outcomes Emergency departmentÀÇ daily outcomes´Â ȯÀÚ Ä¡·áÀÇ Áú°ú È¿À²¼ºÀ» Æò°¡ÇÔ¿¡ ÀÖ¾î ÇÙ½ÉÀûÀÎ ¿ä¼Ò´Ù. ÀÌ outcomes´Â ȯÀÚÀÇ ¾ÈÀü¼º°ú Ä¡·á ¼º°ú¸¦ ÃøÁ¤Çϸç, ÀÇ·á ¼­ºñ½º°¡ Á¦°øµÇ´Â °úÁ¤¿¡¼­ ¹ß»ýÇÏ´Â ´Ù¾çÇÑ ÁöÇ¥¸¦ Æ÷ÇÔ¡¦
·¹Æ÷Æ® > ÀǾຸ°Ç   6page   3,000 ¿ø
Critical Thinking °úÁ¦(´ëü°úÁ¦)

Critical Thinking °úÁ¦(´ëü°úÁ¦)

Critical Thinking °úÁ¦(´ëü°úÁ¦) / (1) There are several risk factors for coronary artery disease (CAD). For each risk factor listed, mark whether it is non-modifiable or modifiable. (2) Circle the non-modifiable and modifiable risk factors that apply to Thomas. (3) Which lab values are of concern at this time Explain your answers. (4) Thomas asks you, ¡°¡¦
·¹Æ÷Æ® > ÀǾຸ°Ç   7page   3,000 ¿ø
·Î·»Áî(Lorenz)ÀÇ °¢ÀÎÇö»ó¿¡¼­ °áÁ¤Àû½Ã±â(critical period)` °³³ä ÀÌÇØ

·Î·»Áî(Lorenz)ÀÇ °¢ÀÎÇö»ó¿¡¼­ °áÁ¤Àû½Ã±â(critical period)` °³³ä ÀÌÇØ

¥°. ¼­·Ð ·Î·»ÁîÀÇ °¢ÀÎÇö»óÀº µ¿¹° ÇൿÇп¡¼­ Áß¿äÇÑ °³³äÀ¸·Î, ƯÁ¤ »ý¹°Ã¼°¡ ž ÈÄ °¡Àå ¹Î°¨ÇÑ ½Ã±â¿¡ ƯÁ¤ÇÑ ´ë»óÀ» ÀνÄÇÏ°í ±× ´ë»óÀ».. / ¥°. ¼­·Ð ¥±. º»·Ð 1. °¢ÀÎ ¹× °áÁ¤Àû ½Ã±â 2. °áÁ¤Àû ½Ã±â ÀÌÈÄ Å¸ÀΰúÀÇ °ü°è Çü¼º 3. ±³»ç·Î¼­ÀÇ °áÁ¤Àû ½Ã±â ¥². °á·Ð ¥³. Âü°í¹®Çå / ¥°. ¼­·Ð ·Î·»ÁîÀÇ °¢ÀÎÇö»óÀº µ¿¹° ÇൿÇп¡¼­ Áß¿äÇÑ °³³äÀ¸·Î, ƯÁ¤ »ý¹°Ã¼°¡¡¦
¹æ¼ÛÅë½Å > ±âŸ   5page   3,000 ¿ø
·Î·»Áî(Lorenz)ÀÇ °¢ÀÎÇö»ó¿¡¼­ °áÁ¤Àû½Ã±â(critical period)` °³³ä ÀÌÇØ

·Î·»Áî(Lorenz)ÀÇ °¢ÀÎÇö»ó¿¡¼­ °áÁ¤Àû½Ã±â(critical period)` °³³ä ÀÌÇØ

¥°. ¼­·Ð ·Î·»ÁîÀÇ °¢ÀÎÇö»óÀº µ¿¹° ÇൿÇп¡¼­ Áß¿äÇÑ °³³äÀ¸·Î, ƯÁ¤ »ý¹°Ã¼°¡ ž ÈÄ °¡Àå ¹Î°¨ÇÑ ½Ã±â¿¡ ƯÁ¤ÇÑ ´ë»óÀ» ÀνÄÇÏ°í ±× ´ë»óÀ».. / ¥°. ¼­·Ð ¥±. º»·Ð 1. °¢ÀÎ ¹× °áÁ¤Àû ½Ã±â 2. °áÁ¤Àû ½Ã±â ÀÌÈÄ Å¸ÀΰúÀÇ °ü°è Çü¼º 3. ±³»ç·Î¼­ÀÇ °áÁ¤Àû ½Ã±â ¥². °á·Ð ¥³. Âü°í¹®Çå / ¥°. ¼­·Ð ·Î·»ÁîÀÇ °¢ÀÎÇö»óÀº µ¿¹° ÇൿÇп¡¼­ Áß¿äÇÑ °³³äÀ¸·Î, ƯÁ¤ »ý¹°Ã¼°¡¡¦
¹æ¼ÛÅë½Å > ±âŸ   5page   2,000 ¿ø




ȸ»ç¼Ò°³ | ÀÌ¿ë¾à°ü | °³ÀÎÁ¤º¸Ãë±Þ¹æħ | °í°´¼¾ÅÍ ¤Ó olle@olleSoft.co.kr
¿Ã·¹¼ÒÇÁÆ® | »ç¾÷ÀÚ : 408-04-51642 ¤Ó ±¤ÁÖ±¤¿ª½Ã ±¤»ê±¸ ¹«Áø´ë·Î 326-6, 201È£ | äÈñÁØ | Åë½Å : ±¤»ê0561È£
Copyright¨Ï ¿Ã·¹¼ÒÇÁÆ® All rights reserved | Tel.070-8744-9518
ÀÌ¿ë¾à°ü | °³ÀÎÁ¤º¸Ãë±Þ¹æħ ¤Ó °í°´¼¾ÅÍ ¤Ó olle@olleSoft.co.kr
¿Ã·¹¼ÒÇÁÆ® | »ç¾÷ÀÚ : 408-04-51642 | Tel.070-8744-9518